• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Reports of myocarditis in healthy adolescents after Pfizer-BioNTech COVID-19 Vaccination

byAlexa FineandAlex Gipsman, MD
June 9, 2021
in Cardiology, Chronic Disease, Infectious Disease, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

 1. In a case series, 7 healthy male adolescents aged 14-19 developed acute myocarditis or myopericarditis within 4 days of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine.

2. All patients recovered rapidly after treatment with non-steroidal anti-inflammatory (NSAID) medications, intravenous immune globulin, and/or corticosteroids. It is unknown whether these cases are causally linked to vaccination.

Evidence Rating Level: 3 (Average)

Study Rundown: Myocarditis is a rare condition in pediatrics, and is a known but rare side effect of the smallpox vaccine. While the COVID-19 mRNA vaccines have been shown to be safe, less is known about rare safety signals associated with immunization. This case series described seven cases of acute myocarditis or myopericarditis in healthy male adolescents that occurred within four days after vaccination with the second dose of the Pfizer mRNA vaccine. The patients ranged from age 14-19 and all presented with chest pain. Cardiac MRI was diagnostic for myocarditis in all individuals. Other causes of myocarditis were ruled out using nasopharyngeal swabs, serum PCR tests, and infectious serologies. Six patients were treated with NSAIDs, four received intravenous immune globulin and oral prednisone, and one patient additionally received high-dose methylprednisolone. All patients subsequently recovered rapidly. Major limitations of the study include its small sample size and the fact that cases were accrued via communication between colleagues rather than a national database. Overall, the study highlights a possible temporal link between the COVID-19 vaccine and post-immunization myocarditis. This diagnosis should be considered when evaluating adolescents for chest pain following a recent COVID-19 vaccination. This consideration may spare patients from undergoing unnecessary invasive procedures such as cardiac catheterization.

Click to read the study in PEDIATRICS

Relevant Reading: Myocarditis following COVID-19 mRNA vaccination

RELATED REPORTS

Safety of investigational vaccines against human immunodeficiency virus

Complicated cases of severe dengue rarely occur in infected travelers

Meta-analysis details short-term outcomes of SARS-CoV-2 mRNA vaccine-associated myopericarditis in adolescents and young adults

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: covid vaccineMyocarditis
Previous Post

Rapid respiratory pathogen testing does not significantly alter antibiotic prescription rates among children with acute respiratory illness

Next Post

Voclosporin shows clinical promise for treatment of active lupus nephritis

RelatedReports

Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
Incidence and severity of dengue in pediatric patients higher in Southeast Asia versus Latin America
Infectious Disease

Complicated cases of severe dengue rarely occur in infected travelers

July 14, 2023
Compliance-linked incentives increase infant immunizations rates in rural India
Cardiology

Meta-analysis details short-term outcomes of SARS-CoV-2 mRNA vaccine-associated myopericarditis in adolescents and young adults

January 3, 2023
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Cardiology

Slight increase of incidence of myocarditis post-mRNA SARS-CoV-2 vaccination

December 15, 2022
Next Post
Multidrug induction therapy increases remission from lupus nephritis

Voclosporin shows clinical promise for treatment of active lupus nephritis

#VisualAbstract: Reduced-dose glucocorticoid adjunct non-inferior to high-dose glucocorticoid plus rituximab regimen for induction of disease remission in autoimmune vasculitis

#VisualAbstract: High-dose methylprednisolone vs. dexamethasone for COVID-19 pneumonia

#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma

#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Increased rates of unmet social needs observed shortly following a diagnosis of dementia
  • Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma
  • Bedtime dosing of antihypertensive medications may provide improved outcomes over morning dosing
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.